Warehouse Overstock Promotion |  Save 10%  on Premium Lab Supplies |  Shop Now

Menu

This product has been added to the cart.

Recombinant Rat EGFR/ErbB1 Protein (His Tag)(Active)

SKU: PKSR030363-100

  • $ 82395
  • Save $ 9900


Request a Quote

Recombinant Rat EGFR/ErbB1 Protein (His Tag)(Active)

 

SKU # PKSR030363
Expression Host HEK293 Cells

 

 

Description

Synonyms EGFR
Species Rat
Expression Host HEK293 Cells
Sequence Met1-Ser646
Accession E7CXR8
Calculated Molecular Weight 70.7 kDa
Observed Molecular Weight 93-110 kDa
Tag C-His
Bio-activity Measured by its ability to bind recombinant human EGF-Fc and mouse EGF-Fc in functional ELISA.
  

 

Properties

Purity > 98 % as determined by reducing SDS-PAGE.
Endotoxin Please contact us for more information.
Storage Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping This product is provided as lyophilized powder which is shipped with ice packs.
Formulation Lyophilized from sterile PBS, pH 7.4
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.
Reconstitution Please refer to the printed manual for detailed information.

 

 

Background

As a member of the epidermal growth factor receptor (EGFR) family, EGFR protein is type I transmembrane glycoprotein that binds a subset of EGF family ligands including EGF, amphiregulin, TGF-&alpha;, betacellulin, etc. EGFR protein plays a crucial role in signaling pathway in the regulation of cell proliferation, survival and differentiation. Binding of a ligand induces EGFR protein homo- or heterodimerization, the subsequent tyrosine autophosphorylation and initiates various down stream pathways (MAPK, PI3K/PKB and STAT). In addition, EGFR signaling also has been shown to exert action on carcinogenesis and disease progression, and thus EGFR protein is proposed as a target for cancer therapy currently.